Advanced Medicine

2022 is well underway, and with it comes The Medicine Maker Company of the Year Awards. Our old faithful Power List is back too.

Gene therapy can help millions of patients with rare diseases, but one hurdle is preventing the field from achieving liftoff.

Building and managing an advanced therapy collection network is a significant challenge, but there is another route.

Allergies pose a significant challenge to patients worldwide. How can we use novel immunotherapy approaches to lessen their therapeutic burden?

SynaptixBio’s CEO discusses the personal road that led him to the fight against the rare disease H-ABC.

Experts explain how cell therapies can tackle tumors in our 2021 supplement on cell and gene therapies.

Join the Curator for a look back on 12 months of top stories from cell and gene therapy’s avant garde.

Panels, thought leaders, and spicy opinions! Here’s a roundup of our best video content of 2021.

Creating more efficient preclinical processes could streamline the route to market for valuable therapies.

A virtual meeting held by the UK Cell and Gene Catapult shared a year of progress, and thoughts on the challenges that lie ahead for British ATMPs.